Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Phillies’ Second Baseman Galvis Suspended After Failed Drug Test

June 20 (Bloomberg) -- Philadelphia Phillies second baseman Freddy Galvis, who hasn’t played in two weeks because of a fractured back, has been suspended 50 games for violating Major League Baseball’s drug policy.

Galvis, 22, tested positive for clostebol, an anabolic steroid, according to a statement yesterday from the office of MLB Commissioner Bud Selig.

“The Phillies continue to believe in and endorse Major League Baseball’s drug policy,” the team said in an e-mailed release. “We also support Freddy Galvis in his determination to put this matter behind him and we look forward to his return as a productive member of the Phillies as soon as possible.”

The team also released a statement on Galvis’s behalf in which the second baseman said a “trace amount” -- 80 parts in a trillion -- of the substance was found during the test.

“I am extremely disappointed in what has transpired,” he said. “I cannot understand how even this tiny particle of a banned substance got into my body. I have not and never would knowingly use anything illegal to enhance my performance.”

Galvis apologized to fans, and accepted baseball’s punishment.

A native of Venezuela, Galvis is hitting .226 with three home runs and 24 runs batted in over 58 games in his first MLB season. He had been filling in at second base for the injured Chase Utley until injuring his back, and has not played since June 6.

To contact the reporter on this story: Eben Novy-Williams in New York at enovywilliam@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.